| For: | Kotsifa E, Saffioti F, Mavroeidis VK. Cholangiocarcinoma: The era of liquid biopsy. World J Gastroenterol 2025; 31(11): 104170 [PMID: 40124277 DOI: 10.3748/wjg.v31.i11.104170] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i11/104170.htm |
| Number | Citing Articles |
| 1 |
Helen Winter, James Korolewicz. Bile Duct Cancer Treatment and Research - Latest Developments. Oncology 2025; 8 doi: 10.5772/intechopen.1011665
|
| 2 |
Jingnan Xue, Longhao Zhang, Kai Zhang, Yu Wu, Kai Zhou, Xin Lu. Metabolic collusion driving immune evasion in cholangiocarcinoma: unmasking the dual control of the immuno-metabolic microenvironment. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1697056
|
| 3 |
Yawen Dong, Hannah E. Stumpf, Rory L. Smoot, Patrick P. Starlinger, Mark M. Yarchoan, Gregory J. Gores, Sumera I. Ilyas. Anatomic subsets of cholangiocarcinoma: More different than alike. Hepatology 2026; doi: 10.1097/HEP.0000000000001672
|
| 4 |
Michael Osseis, Christian Mouawad. Microscopically Incomplete Resection (R1) of Intrahepatic Cholangiocarcinoma: What’s the Next Step?. Indian Journal of Surgical Oncology 2026; doi: 10.1007/s13193-025-02496-1
|
